Plain‑language drug resistant epilepsy research: who benefits from surgery, devices, diets, and emerging treatments.
A study was conducted to understand the effects of tracheostomy in critically ill children with neurological impairments who were treated in the Pediatric Intensive Care Unit (PICU).
This study looked at how machine learning (ML) can help doctors make better decisions about surgery for people with drug-resistant epilepsy (DRE).
Researchers studied the effects of a treatment called central responsive neurostimulation (RNS) on children with drug-resistant epilepsy (DRE) that affects multiple areas of the brain.
This study focused on children with Tuberous Sclerosis Complex (TSC), a genetic condition that can cause various health issues, including tumors in different organs and early-onset epilepsy.
This study looked at treatments for two serious conditions in children: new onset refractory status epilepticus (a type of severe seizure) and febrile infection-related epilepsy syndrome (a condition that can cause seizures after a fever).
This study looked at the cost-effectiveness of a medication called brivaracetam (BRV) for treating patients in Jordan who have focal-onset seizures that do not respond to other treatments.
A recent study looked at how doctors in Germany, Austria, and Switzerland treat a serious condition called status epilepticus (SE), which is a prolonged seizure that can be life-threatening.
Researchers studied how to improve surgical strategies for patients with drug-resistant temporal lobe epilepsy (TLE) using a method called stereo-electroencephalography (SEEG).
Researchers studied how effective a specific brain stimulation treatment is for children with difficult-to-treat epilepsy.